90 results
8-K
EX-99.1
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
and development expenses: Research and development expenses during the fourth quarter of 2023 were $4.7 million, compared to $4.4 million during the fourth … by a decrease in interest income on cash investments.
Full Year 2023 Financial Results
Research and development expenses: Research and development
8-K
EX-99.2
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
. 31, 2022 Operating expenses: Research and development, net of grants 4,708$ 4,427$ 16,968$ 14,169$ General and administrative, net of grants 1,509
424B5
buv1p
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
9w33n7uhx7i92nb5y8l
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
b4jz3 0592iq76w0xmt
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
lfzynrne
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
xxp0oei pg05d5mj
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.1
uiqoeg6yuc1g4i8
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm
8-K
EX-99.2
eak4o6jzh c0
15 May 23
Results of Operations and Financial Condition
6:49am
8-K
EX-99.1
8n56l q12dfksco09m
15 May 23
Results of Operations and Financial Condition
6:49am
DEFR14A
3ipy jof38ab4qsh6
1 May 23
Revised proxy
4:49pm